Showing results (151-160 of 333) with videos related to
Sort By:
Pageof 34
The Journal of Veterinary Medical Science|March 20, 2004
A potential live vector, foamy virus, directed intra-cellular expression of ovine interferon-tau exhibited the resistance to HIV infectionYoichi Fujii, Yasunori Murase, Kaori Otake, et al.International Journal of Clinical Oncology|August 27, 2024
A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutationsKiyotaka Yoh, Koichi Azuma, Hidetoshi Hayashi, et al.Biological & Pharmaceutical Bulletin|June 2, 2007
Dihydrotestosterone inhibits tumor necrosis factor alpha induced interleukin-1alpha mRNA expression in rheumatoid fibroblast-like synovial cellsYuka Itoh, Hidetoshi Hayashi, Jian Xu, et al.International Journal of Clinical Oncology|April 7, 2021
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysisKatsuyuki Hotta, Makoto Nishio, Haruhiro Saito, et al.Oncotarget|November 9, 2017
Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancerHiroto Ueda, Masayuki Takeda, Shinya Ueda, et al.Clinical Lung Cancer|December 10, 2021
Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non-Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L)Naoki Haratake, Hidetoshi Hayashi, Mototsugu Shimokawa, et al.BMC Pulmonary Medicine|May 9, 2021
Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancerOsamu Nishiyama, Shigeki Shimizu, Koji Haratani, et al.Molecules (Basel, Switzerland)|June 13, 2018
Anti-Tumorigenic Activity of Chrysin from <i>Oroxylum indicum</i> via Non-Genotoxic p53 Activation through the ATM-Chk2 PathwayMai Nagasaka, Ryoko Hashimoto, Yasumichi Inoue, et al.Cancer Chemotherapy and Pharmacology|August 20, 2011
Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancerTaroh Satoh, Yasuhide Yamada, Kei Muro, et al.Journal of Natural Medicines|February 18, 2022
Suppressive effects of processed aconite root on dexamethasone-induced muscle ring finger protein-1 expression and its active ingredientsTaishi Kondo, Tomoaki Ishida, Ke Ye, et al.Pageof 34